No Data
Linuo Pharmaceutical Package (301188.SZ): The controlling Shareholder has cumulatively increased their Shareholding by 1.3635%.
On January 7, Glonghui reported that Lino Pharmaceutical (301188.SZ) announced receipt of a notification letter from its controlling shareholder, Lino Investment Holding Group Co., Ltd., regarding the shareholding increase. From January 3, 2025, to January 6, 2025, Lino Investment increased its shareholding in the company by a total of 3,121,454 shares through the trading system of the Shenzhen Stock Exchange via centralized bidding, accounting for 1.3635% of the company's current total share capital (excluding repurchased shares). As of January 6, 2025, Lino Investment has already increased its share ratio according to the plan to over 1%.
Linuo Pharmaceutical (301188.SZ): Some fundraising projects and Convertible Bonds fundraising projects are proposed to be postponed.
On December 18, 2023, Longgui announced that Lino Pharmaceuticals (301188.SZ) convened the seventh meeting of the fourth Board of Directors and the sixth meeting of the fourth Supervisory Board, where it was approved to delay the "Proposal on the Delay of Certain Fundraising Projects of the Initial Public Offering and Convertible Bonds Projects." The company agreed to maintain the implementation subject, total investment, and use of funds for the fundraising projects without changes, and according to the current actual construction progress of the fundraising projects, to proceed with the "Neutral Borosilicate Medicinal Glass Expansion Project" and the "High Borosilicate Glass Production Project for Led & Optoelectronics Optical Lenses."
Debon Securities: The scale of borosilicate pharmaceutical glass is continuously expanding. Pay attention to the improvement in profitability within the industry as costs decline.
National centralized procurement promotes the adoption of pharmaceuticals with medium borosilicate packaging, expanding the market size of medium borosilicate pharmaceutical glass.
Here's Why Shandong Linuo Pharmaceutical Packaging (SZSE:301188) Can Manage Its Debt Responsibly
Linuo Te Bo (301188.SZ): The stock name will change to 'Linuo Pharmaceutical Packaging' starting from November 25.
Gelonghui November 22nd | Linnuo Glass (301188.SZ) announced that, upon the company's application and approval by the Shenzhen Stock Exchange, the company's securities abbreviation will be changed starting from November 25, 2024. The new abbreviation will be "Linuo Yaobao". The company's securities code "301188" remains unchanged.
Linuo Te Bo (301188.SZ): Fosun Weishi and its concerted parties plan to reduce their shareholding by no more than 3%.
On November 13, Gelonghui announced that Jinan Caijin Fuxing Wealthy Real Equity Investment Fund Partnership Enterprise (Limited Partnership), referred to as "Fuxing Wei Shi", holds 8,742,997 shares of the company (accounting for 3.7612% of the company's total share capital, and 3.8191% of the total share capital excluding the quantity of repurchase securities in the account) and also holds 8,743,097 shares of Linuotebo (301188.SZ) (accounting for 3.7613% of the company's total share capital, and 3.8192% of the total share capital excluding the quantity of repurchase securities in the account) in a consistent manner.
There Are Reasons To Feel Uneasy About Shandong Linuo Technical GlassLtd's (SZSE:301188) Returns On Capital
